List of Excipients in API OSELTAMIVIR PHOSPHATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing OSELTAMIVIR PHOSPHATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | CROSCARMELLOSE SODIUM | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | FD&C BLUE NO. 2 | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | FERRIC OXIDE RED | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | FERRIC OXIDE YELLOW | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | GELATIN | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | POVIDONE K30 | |
| Genentech Inc | TAMIFLU | oseltamivir phosphate | 0004-0802 | SHELLAC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing OSELTAMIVIR PHOSPHATE
Detailed excipient profiles for OSELTAMIVIR PHOSPHATE
Excipient focus: .ALPHA.-TOCOPHEROL, DL-
OSELTAMIVIR PHOSPHATE drug variants containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oseltamivir phosphate | 0093-8180 |
| A-S Medication Solutions | oseltamivir phosphate | 50090-4613 |
| Aurobindo Pharma Limited | oseltamivir phosphate | 59651-597 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing .ALPHA.-TOCOPHEROL, DL-
Excipient focus: ALCOHOL
OSELTAMIVIR PHOSPHATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | oseltamivir phosphate | 47781-468 |
| Aidarex Pharmaceuticals LLC | oseltamivir phosphate | 53217-280 |
| McKesson Corporation dba SKY Packaging | oseltamivir phosphate | 63739-038 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing ALCOHOL
Excipient focus: AMMONIA
OSELTAMIVIR PHOSPHATE drug variants containing AMMONIA
OSELTAMIVIR PHOSPHATE drug variants not containing AMMONIA
Excipient focus: BENZYL ALCOHOL
OSELTAMIVIR PHOSPHATE drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oseltamivir phosphate | 0093-8180 |
| A-S Medication Solutions | oseltamivir phosphate | 50090-4613 |
| Aurobindo Pharma Limited | oseltamivir phosphate | 59651-597 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing BENZYL ALCOHOL
Excipient focus: BUTYL ALCOHOL
OSELTAMIVIR PHOSPHATE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | oseltamivir phosphate | 47781-468 |
| Aidarex Pharmaceuticals LLC | oseltamivir phosphate | 53217-280 |
| McKesson Corporation dba SKY Packaging | oseltamivir phosphate | 63739-038 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing BUTYL ALCOHOL
Excipient focus: CROSCARMELLOSE SODIUM
OSELTAMIVIR PHOSPHATE drug variants containing CROSCARMELLOSE SODIUM
OSELTAMIVIR PHOSPHATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 28
OSELTAMIVIR PHOSPHATE drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oseltamivir phosphate | 50090-3718 |
| RPK Pharmaceuticals Inc | oseltamivir phosphate | 53002-1387 |
| RedPharm Drug | oseltamivir phosphate | 67296-1514 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing D&C RED NO. 28
Excipient focus: FD&C BLUE NO. 1
OSELTAMIVIR PHOSPHATE drug variants containing FD&C BLUE NO. 1
OSELTAMIVIR PHOSPHATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
OSELTAMIVIR PHOSPHATE drug variants containing FD&C BLUE NO. 2
OSELTAMIVIR PHOSPHATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
OSELTAMIVIR PHOSPHATE drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | oseltamivir phosphate | 42385-985 |
| Exelan Pharmaceuticals Inc | oseltamivir phosphate | 76282-702 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Excipient focus: FD&C RED NO. 3
OSELTAMIVIR PHOSPHATE drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Hainan Poly Pharm Co Ltd | oseltamivir phosphate | 14335-380 |
| Slate Run Pharmaceuticals LLC | oseltamivir phosphate | 70436-225 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
OSELTAMIVIR PHOSPHATE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oseltamivir phosphate | 50090-3718 |
| RPK Pharmaceuticals Inc | oseltamivir phosphate | 53002-1387 |
| RedPharm Drug | oseltamivir phosphate | 67296-1514 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
OSELTAMIVIR PHOSPHATE drug variants containing FERRIC OXIDE RED
OSELTAMIVIR PHOSPHATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
OSELTAMIVIR PHOSPHATE drug variants containing FERRIC OXIDE YELLOW
OSELTAMIVIR PHOSPHATE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
OSELTAMIVIR PHOSPHATE drug variants containing FERROSOFERRIC OXIDE
OSELTAMIVIR PHOSPHATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
OSELTAMIVIR PHOSPHATE drug variants containing GELATIN
OSELTAMIVIR PHOSPHATE drug variants not containing GELATIN
Excipient focus: ISOPROPYL ALCOHOL
OSELTAMIVIR PHOSPHATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | oseltamivir phosphate | 47781-468 |
| Aidarex Pharmaceuticals LLC | oseltamivir phosphate | 53217-280 |
| McKesson Corporation dba SKY Packaging | oseltamivir phosphate | 63739-038 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MALTODEXTRIN
OSELTAMIVIR PHOSPHATE drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oseltamivir phosphate | 0093-8180 |
| A-S Medication Solutions | oseltamivir phosphate | 50090-4613 |
| Aurobindo Pharma Limited | oseltamivir phosphate | 59651-597 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
OSELTAMIVIR PHOSPHATE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | oseltamivir phosphate | 0527-5137 |
| Sunshine Lake Pharma Co Ltd | oseltamivir phosphate | 48792-7914 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing MANNITOL
Excipient focus: MONOSODIUM CITRATE
OSELTAMIVIR PHOSPHATE drug variants containing MONOSODIUM CITRATE
OSELTAMIVIR PHOSPHATE drug variants not containing MONOSODIUM CITRATE
Excipient focus: POTASSIUM HYDROXIDE
OSELTAMIVIR PHOSPHATE drug variants containing POTASSIUM HYDROXIDE
OSELTAMIVIR PHOSPHATE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
OSELTAMIVIR PHOSPHATE drug variants containing POVIDONE
OSELTAMIVIR PHOSPHATE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
OSELTAMIVIR PHOSPHATE drug variants containing POVIDONE K30
OSELTAMIVIR PHOSPHATE drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
OSELTAMIVIR PHOSPHATE drug variants containing PROPYLENE GLYCOL
OSELTAMIVIR PHOSPHATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
OSELTAMIVIR PHOSPHATE drug variants containing SACCHARIN SODIUM
OSELTAMIVIR PHOSPHATE drug variants not containing SACCHARIN SODIUM
Excipient focus: SACCHARIN SODIUM DIHYDRATE
OSELTAMIVIR PHOSPHATE drug variants containing SACCHARIN SODIUM DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | oseltamivir phosphate | 42254-092 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing SACCHARIN SODIUM DIHYDRATE
Excipient focus: SHELLAC
OSELTAMIVIR PHOSPHATE drug variants containing SHELLAC
OSELTAMIVIR PHOSPHATE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
OSELTAMIVIR PHOSPHATE drug variants containing SILICON DIOXIDE
OSELTAMIVIR PHOSPHATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
OSELTAMIVIR PHOSPHATE drug variants containing SODIUM BENZOATE
OSELTAMIVIR PHOSPHATE drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CITRATE
OSELTAMIVIR PHOSPHATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | oseltamivir phosphate | 27241-139 |
| Preferred Pharmaceuticals Inc | oseltamivir phosphate | 68788-8123 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM LAURYL SULFATE
OSELTAMIVIR PHOSPHATE drug variants containing SODIUM LAURYL SULFATE
OSELTAMIVIR PHOSPHATE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
OSELTAMIVIR PHOSPHATE drug variants containing SODIUM STEARYL FUMARATE
OSELTAMIVIR PHOSPHATE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SORBITOL
OSELTAMIVIR PHOSPHATE drug variants containing SORBITOL
OSELTAMIVIR PHOSPHATE drug variants not containing SORBITOL
Excipient focus: SOUR CHERRY
OSELTAMIVIR PHOSPHATE drug variants containing SOUR CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | oseltamivir phosphate | 0527-5137 |
| Sunshine Lake Pharma Co Ltd | oseltamivir phosphate | 48792-7914 |
| >Company | >Ingredient | >NDC |
OSELTAMIVIR PHOSPHATE drug variants not containing SOUR CHERRY
Excipient focus: STARCH, CORN
OSELTAMIVIR PHOSPHATE drug variants containing STARCH, CORN
OSELTAMIVIR PHOSPHATE drug variants not containing STARCH, CORN
Excipient focus: TALC
OSELTAMIVIR PHOSPHATE drug variants containing TALC
OSELTAMIVIR PHOSPHATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
OSELTAMIVIR PHOSPHATE drug variants containing TITANIUM DIOXIDE
OSELTAMIVIR PHOSPHATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
OSELTAMIVIR PHOSPHATE drug variants containing WATER
OSELTAMIVIR PHOSPHATE drug variants not containing WATER
Excipient focus: XANTHAN GUM
OSELTAMIVIR PHOSPHATE drug variants containing XANTHAN GUM
OSELTAMIVIR PHOSPHATE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
